Novartis

Narasimhan
Biotech

Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts

Novartis is “continuing to evaluate” the in vivo CAR-T space, although the pharma’s CEO told Fierce Biotech that no deals are currently in the works.
James Waldron Apr 28, 2026 3:21am
Cutting branch off a tree with a chainsaw

Novartis narrows anticoagulant's focus after losing to Eliquis

Apr 22, 2026 4:00am
Narasimhan
Favicon Fierce Pharma

Novartis CEO Vas Narasimhan joins Anthropic's board

Apr 15, 2026 10:36am
Statue in Vienna of Heracles battling the hydra

The 'diabolical' molecule set to become biotech's next gold rush

Apr 9, 2026 8:00am
Leo Pharma lion
Favicon Fierce Pharma

M&A surge triggers high expectations for 2026

Apr 6, 2026 5:00am
blocks coins money

Syneron closes $150M round to support peptide platform

Apr 3, 2026 9:31am